Therapeutic Market Research Reports
Sort By
| Title | Published | Price |
|---|---|---|
| Revance Therapeutics Inc (RVNC) - Financial and Strategic SWOT Analysis Review
By GlobalData
Revance Therapeutics Inc (RVNC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unb... |
Jun 2021 | $ 125 |
| Sangamo Therapeutics Inc (SGMO) - Financial and Strategic SWOT Analysis Review
By GlobalData
Sangamo Therapeutics Inc (SGMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unb... |
Jun 2021 | $ 125 |
| Coronavirus Disease 2019 (COVID-19) Clinical Trials - Overview, Landscape, Trial using Vaccines vs. Therapeutics,and Trials Impacted by COVID-19
By GlobalData
Coronavirus Disease 2019 (COVID-19) Clinical Trials - Overview, Landscape, Trial using Vaccines vs. Therapeutics,and Trials Impacted by COVID-19
Summary
This report provides an overview of global COVID-19 clinical trials ext... |
May 2021 | $ 695 |
| Trillium Therapeutics Inc (TRIL) - Financial and Strategic SWOT Analysis Review
By GlobalData
Trillium Therapeutics Inc (TRIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an un... |
May 2021 | $ 125 |
| Addex Therapeutics Ltd (ADXN) - Financial and Strategic SWOT Analysis Review
By GlobalData
Addex Therapeutics Ltd (ADXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbia... |
May 2021 | $ 125 |
| Checkpoint Therapeutics Inc (CKPT) - Financial and Strategic SWOT Analysis Review
By GlobalData
Checkpoint Therapeutics Inc (CKPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an ... |
May 2021 | $ 125 |
| PTC Therapeutics Inc (PTCT) - Financial and Strategic SWOT Analysis Review
By GlobalData
PTC Therapeutics Inc (PTCT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiase... |
May 2021 | $ 125 |
| Northwest Biotherapeutics Inc (NWBO) - Financial and Strategic SWOT Analysis Review
By GlobalData
Northwest Biotherapeutics Inc (NWBO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and a... |
Apr 2021 | $ 125 |
| Sage Therapeutics Inc (SAGE) - Financial and Strategic SWOT Analysis Review
By GlobalData
Sage Therapeutics Inc (SAGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbias... |
Apr 2021 | $ 125 |
| United Therapeutics Corp (UTHR) - Financial and Strategic SWOT Analysis Review
By GlobalData
United Therapeutics Corp (UTHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unb... |
Apr 2021 | $ 125 |
| Plus Therapeutics Inc (PSTV) - Financial and Strategic SWOT Analysis Review
By GlobalData
Plus Therapeutics Inc (PSTV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbias... |
Apr 2021 | $ 125 |
| Inhibitor Therapeutics Inc (INTI) - Financial and Strategic SWOT Analysis Review
By GlobalData
Inhibitor Therapeutics Inc (INTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an u... |
Apr 2021 | $ 125 |
| Aptevo Therapeutics Inc (APVO) - Financial and Strategic SWOT Analysis Review
By GlobalData
Aptevo Therapeutics Inc (APVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbi... |
Apr 2021 | $ 125 |
| Karyopharm Therapeutics Inc (KPTI) - Financial and Strategic SWOT Analysis Review
By GlobalData
Karyopharm Therapeutics Inc (KPTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an ... |
Apr 2021 | $ 125 |
| Nektar Therapeutics (NKTR) - Financial and Strategic SWOT Analysis Review
By GlobalData
Nektar Therapeutics (NKTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased... |
Apr 2021 | $ 125 |
| Halozyme Therapeutics Inc (HALO) - Financial and Strategic SWOT Analysis Review
By GlobalData
Halozyme Therapeutics Inc (HALO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an un... |
Apr 2021 | $ 125 |
| Protalix BioTherapeutics Inc (PLX) - Financial and Strategic SWOT Analysis Review
By GlobalData
Protalix BioTherapeutics Inc (PLX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an ... |
Apr 2021 | $ 125 |
| CymaBay Therapeutics Inc (CBAY) - Financial and Strategic SWOT Analysis Review
By GlobalData
CymaBay Therapeutics Inc (CBAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unb... |
Apr 2021 | $ 125 |
| Intellia Therapeutics Inc (NTLA) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary
Intellia Therapeutics Inc (Intellia Therapeutics) is a genome editing company. It develops proprietary curative therapeutics using CRISPR/Cas9 technology. The company develops in vivo programs for the treatment of liver diseases ... |
Apr 2021 | $ 300 |
| Crescita Therapeutics Inc (CTX) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary
Crescita Therapeutics Inc (Crescita Therapeutics) operates as a commercial dermatology company that offers prescription drug products for the treatment and care of skin conditions and diseases and their symptoms. The company's pr... |
Apr 2021 | $ 300 |
| DiaMedica Therapeutics Inc (DMA) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary
DiaMedica Therapeutics Inc (DiaMedica) formerly DiaMedica Inc, is a clinical-stage bio pharmaceutical company which develops innovative medicines for the treatment neurological and kidney diseases. Its lead product candidate DM-1... |
Apr 2021 | $ 300 |
| Global Blood Therapeutics Inc (GBT) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary
Global Blood Therapeutics Inc (GBT) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes novel oral medicines for the treatment of grievous blood-based disorders. The company's lead drug candi... |
Apr 2021 | $ 300 |
| Knight Therapeutics Inc (GUD) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary
Knight Therapeutics Inc (Knight Therapeutics) focuses on acquisition, licensing, marketing and distribution of prescription, consumer health products and medical devices. The company offers tablets to treat metabolic, renal disea... |
Apr 2021 | $ 300 |
| Pluristem Therapeutics Inc (PSTI) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary
Pluristem Therapeutics Inc (Pluristem) operates as a clinical-stage biotherapy company that focuses on the development of placental-derived cell therapies. Its PLacental eXpanded (PLX) cells are adherent stromal cells that can be... |
Apr 2021 | $ 300 |
| Bone Therapeutics SA (BOTHE) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary
Bone Therapeutics SA (Bone Therapeutics) is a cell therapy company that develops autologous and allogeneic cell therapy products. It offers pipeline products such as PREOB, an autologous osteoblastic cell therapy product used for... |
Apr 2021 | $ 300 |